According to CTI BioPharma 's latest financial reports the company's current EPS (TTM) is -$0.97. In 2022 the company made an earnings per share (EPS) of -$1.43 an increase over its 2021 EPS that were of -$1.81.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.94 | -33.79% |
2022 | -$1.43 | -21.3% |
2021 | -$1.81 | 45.95% |
2020 | -$1.24 | 7.25% |
2019 | -$1.16 | 30.19% |
2018 | -$0.89 | -58.91% |
2017 | -$2.16 | -29.12% |
2016 | -$3.05 | -72.84% |
2015 | -$11.24 | 6.35% |
2014 | -$10.56 |